![Anthony Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Parker
Direktor/Vorstandsmitglied bei
ALLERGY THERAPEUTICS PLC
Vermögen: 181 393 $ am 30.06.2026
Profil
Anthony Michael Parker is the founder of Beagle Partners LLP, founded in 2004, where he holds the title of Partner.
He is also the founder of Argonaute RNA Ltd., founded in 2015, where he holds the title of Chairman.
Currently, Mr. Parker is a Non-Executive Director at Allergy Therapeutics Plc.
He is also a Director at Bristol Bluegreen Ltd., Cbderma Technology Ltd., Inverpharma Ltd., Las Lilas Ltd., and Rosemont Wildwall Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALLERGY THERAPEUTICS PLC 0,03 % | 30.06.2025 | 1.925.000 ( 0,03 % ) | 181 393 $ | 30.06.2026 |
Aktive Positionen von Anthony Parker
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 06.12.2022 |
Beagle Partners LLP
 Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Vorstandsvorsitzender | 01.01.2004 |
Argonaute RNA Ltd.
 Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Gründer | 01.01.2015 |
Bristol Bluegreen Ltd.
 Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Direktor/Vorstandsmitglied | - |
Cbderma Technology Ltd. | Direktor/Vorstandsmitglied | - |
Inverpharma Ltd. | Direktor/Vorstandsmitglied | - |
Las Lilas Ltd. | Direktor/Vorstandsmitglied | - |
Rosemont Wildwall Ltd. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Allergy Therapeutics Plc
 Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
Beagle Partners LLP
Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Finance |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Commercial Services |
Bristol Bluegreen Ltd.
Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Electronic Technology |
Cbderma Technology Ltd. | |
Inverpharma Ltd. | |
Las Lilas Ltd. | |
Rosemont Wildwall Ltd. |
